Zimmer Biomet Reports First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Zimmer Biomet (ZBH) PT Raised to $153 at Needham & Company; Buy on Weakness
April 27, 2017 1:46 PM EDTNeedham & Company raised its price target on Zimmer Biomet (NYSE: ZBH) to $153.00 (from $151.00) while maintaining a Strong Buy rating but said disappointing Q1 results return the stock to a "show-me story" but they are recommending investors buy on today's weakness.
Analyst Mike... More
Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 2c; Narrows Outlook
April 27, 2017 7:37 AM EDTZimmer Biomet Holdings (NYSE: ZBH) reported Q1 EPS of $2.13, $0.02 better than the analyst estimate of $2.11. Revenue for the quarter came in at $1.98 billion versus the consensus estimate of $1.96 billion.
"Zimmer Biomet delivered first quarter revenue and adjusted earnings growth consistent with our... More



